South Wales, Oct. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "CANTAB PATHWAY" on Oct. 10. The details about the trademark application no. UK00004276135 published in the journal no. 2025/043 (Oct. 24).
With J A Kemp LLP as representative, Cambridge Cognition Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Computer software; computer application software; all of the aforesaid goods for use in relation to the medical field and, in particular, cognitive, psychological, neuropsychological, or psychiatric testing, monitoring, diagnosis, research, analysis, or assessment; Computer software for the collation, analysis, presentation and feedback of medical information and data; Computer software for accessing, reviewing and sharing medical information and data; Computer software for accessing, reviewing and sharing medical information and data relating to medical pathways; Computer software and programmes for accessing web portals and databases containing medical information and data; downloadable publications.
Class 42 : Software as a service [saas]; platform as a service [paas]; all of the aforesaid services for use in relation to the medical field and, in particular, cognitive, psychological, neuropsychological, or psychiatric testing, monitoring, diagnosis, research, analysis, or assessment; Software as a service [saas], namely providing access to medical information and data; Software as a service [saas], namely providing an online platform for analysis, presentation and feedback of medical information and data; Software as a service [saas], namely providing an online platform for accessing, reviewing and sharing information and data relating to healthcare and medical matters; Software as a service [saas], namely providing an online platform for accessing, reviewing and sharing information and data relating to medical pathways; Hosting web portals and databases containing medical information and data; Medical research services; Providing medical and scientific research in relation to medical pathways; Information, advisory and consultancy services relating to the aforesaid; Platform as a service (paas) featuring computer software platforms that allows users access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence in the medical field and, in particular, in relation to cognitive, psychological, neuropsychological, or psychiatric testing, monitoring, diagnosis, research, analysis, or assessment; Platform as a service (paas) featuring computer software platforms that allows users the ability to model patient pathways, and care programs; Computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence in the healthcare including medical pathways; Design and development of computer hardware and software; Scientific and technological services and research all for or relating to cognitive, psychological, neuropsychological, or psychiatric research; Technical support services; Advisory services for or relating to pharmaceutical clinical tests or trials; Advisory services for or relating to cognitive, psychological, neuropsychological, or psychiatric research; Professional consultancy services and provision of information and preparation of reports all for or relating to cognitive, psychological, neuropsychological, or psychiatric research.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004276135
Disclaimer: Curated by HT Syndication.
